{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:07:46Z","timestamp":1792098466065,"version":"4.4.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Aberdeen Development Trust"},{"name":"Farr Institute of Health Informatics Research"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council, the National Institute of Health Research"},{"DOI":"10.13039\/100009250","name":"National Institute for Social Care and Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009250","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scottish Government Health Directorates"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["MR\/K007017\/1"],"award-info":[{"award-number":["MR\/K007017\/1"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Infection exerts a major burden in ANCA-associated vasculitis (AAV), however, its precise extent and nature remains unclear. In this national study we aimed to longitudinally quantify, characterize and contextualize infection risk in AAV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a multicentre matched cohort study of AAV. Complementary data on infections were retrieved via data linkage with the population-based Scottish microbiological laboratory, hospitalization and primary care prescribing registries.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 379 AAV patients and 1859 controls were followed up for a median of 3.5\u2009years (interquartile range 1.9\u20135.7). During follow-up, the proportions of AAV patients with at least one laboratory-confirmed infection, severe infection and primary care antibiotic prescription were 55.4%, 35.6% and 74.6%, respectively. The risk of infection was higher in AAV than in matched controls {laboratory-confirmed infections: incidence rate ratio [IRR] 7.3 [95% confidence interval (CI) 5.6, 9.6]; severe infections: IRR 4.4 [95% CI 3.3, 5.7]; antibiotic prescriptions: IRR 2.2 [95% CI 1.9, 2.6]}. Temporal trend analysis showed that AAV patients remained at a higher risk of infections throughout the follow-up period, especially year 1. Although the Escherichia genus was the most commonly identified pathogen (16.6% of AAV, 5.5% of controls; P\u2009&amp;lt;\u20090.0001), AAV patients had the highest risk for Herpes [IRR 12.5 (95% CI 3.7, 42.6)] and Candida [IRR 11.4 (95% CI 2.4, 55.4)].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>AAV patients have up to seven times higher risk of infection than the general population and the overall risk remains significant after 8\u2009years of follow-up. The testing of enhanced short- to medium-term prophylactic antibiotic regimes should be considered.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa070","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T12:10:29Z","timestamp":1580991029000},"page":"3014-3022","source":"Crossref","is-referenced-by-count":26,"title":["Characterizing infection in anti-neutrophil cytoplasmic antibody\u2013associated vasculitis: results from a longitudinal, matched-cohort data linkage study"],"prefix":"10.1093","volume":"59","author":[{"given":"Shifa H","family":"Sarica","sequence":"first","affiliation":[{"name":"Aberdeen Centre for Health Data Science, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9128-6603","authenticated-orcid":false,"given":"Neeraj","family":"Dhaun","sequence":"additional","affiliation":[{"name":"Queen\u2019s Medical Research Institute, University\/British Heart Foundation Centre of Research Excellence, University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sznajd","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Raigmore Hospital, Inverness, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Harvie","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Raigmore Hospital, Inverness, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McLaren","sequence":"additional","affiliation":[{"name":"Fife Rheumatic Diseases Unit, Whyteman\u2019s Brae Hospital, Kirkcaldy, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"McGeoch","sequence":"additional","affiliation":[{"name":"Centre for Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Kumar","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Ninewells Hospital, Dundee, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Amft","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Medicines Research Centre, Stevenage, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Erwig","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline, Medicines Research Centre, Stevenage, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angharad","family":"Marks","sequence":"additional","affiliation":[{"name":"Morriston Hospital Renal Unit, Abertawe Bro Morgannwg University Health Board, Swansea, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corri","family":"Black","sequence":"additional","affiliation":[{"name":"Aberdeen Centre for Health Data Science, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Basu","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"2020092423551281200_keaa070-B1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2020092423551281200_keaa070-B2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","article-title":"Relapse rate, renal survival, and cancer morbidity in patients with Wegener\u2019s granulomatosis or microscopic polyangiitis with renal involvement","volume":"9","author":"Westman","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"2020092423551281200_keaa070-B3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","article-title":"Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis","volume":"69","author":"Little","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2020092423551281200_keaa070-B4","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.30296","article-title":"Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides","volume":"63","author":"Le Guenno","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2020092423551281200_keaa070-B5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s198-002-8341-z","article-title":"Prevalence of reduced bone mineral density in patients with anti-neutrophil cytoplasmic antibody associated vasculitis and the role of immunosuppressive therapy: a cross-sectional study","volume":"13","author":"Boomsma","year":"2002","journal-title":"Osteoporosis Int"},{"key":"2020092423551281200_keaa070-B6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3476(05)83482-1","article-title":"Wegener granulomatosis in children and adolescents: clinical presentation and outcome","volume":"122","author":"Rottem","year":"1993","journal-title":"J Pediatr"},{"key":"2020092423551281200_keaa070-B7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1378\/chest.109.2.430","article-title":"Wegener\u2019s granulomatosis in the elderly","volume":"109","author":"Krafcik","year":"1996","journal-title":"Chest"},{"key":"2020092423551281200_keaa070-B8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard.2008.088302","article-title":"Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients","volume":"68","author":"Charlier","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2020092423551281200_keaa070-B9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2215\/CJN.07300712","article-title":"Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis","volume":"8","author":"Goupil","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020092423551281200_keaa070-B10","doi-asserted-by":"crossref","first-page":"i171","DOI":"10.1093\/ndt\/gfv045","article-title":"Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function","volume":"30(Suppl 1","author":"McGregor","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2020092423551281200_keaa070-B11","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3899\/jrheum.160909","article-title":"Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"44","author":"Mohammad","year":"2017","journal-title":"J Rheumatol"},{"key":"2020092423551281200_keaa070-B12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12882-018-0933-2","article-title":"Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study","volume":"19","author":"Yang","year":"2018","journal-title":"BMC Nephrol"},{"key":"2020092423551281200_keaa070-B13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/pgmj.2005.034215","article-title":"Clinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre","volume":"81","author":"Chen","year":"2005","journal-title":"Postgrad Med J"},{"key":"2020092423551281200_keaa070-B14","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/qjmed\/hcs015","article-title":"Characteristics of late onset neutropenia in rheumatologic patients treated with rituximab: a case review analysis from a single center","volume":"105","author":"Besada","year":"2012","journal-title":"QJM"},{"key":"2020092423551281200_keaa070-B15","year":"2017"},{"key":"2020092423551281200_keaa070-B16","year":"2016"},{"key":"2020092423551281200_keaa070-B17"},{"key":"2020092423551281200_keaa070-B18","year":"2017"},{"key":"2020092423551281200_keaa070-B19","volume-title":"Guide to prescribing services","year":"2012"},{"key":"2020092423551281200_keaa070-B20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ije\/dyw060","article-title":"Data resource profile: the Scottish National prescribing information system (PIS)","volume":"45","author":"Alvarez-Madrazo","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2020092423551281200_keaa070-B21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2125.1999.00853.x","article-title":"Record-linkage for pharmacovigilance in Scotland","volume":"47","author":"Evans","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"2020092423551281200_keaa070-B22","year":"2015"},{"key":"2020092423551281200_keaa070-B23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2020092423551281200_keaa070-B24","year":"2016"},{"key":"2020092423551281200_keaa070-B25","doi-asserted-by":"crossref","first-page":"e014885","DOI":"10.1136\/bmjopen-2016-014885","article-title":"Defining and measuring suspicion of sepsis: an analysis of routine data","volume":"7","author":"Inada-Kim","year":"2017","journal-title":"BMJ Open"},{"key":"2020092423551281200_keaa070-B26","volume-title":"British National Formulary","year":"2007","edition":"54th edn."},{"key":"2020092423551281200_keaa070-B27","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/dme.12384","article-title":"New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records","volume":"31","author":"McDonald","year":"2014","journal-title":"Diabet Med"},{"key":"2020092423551281200_keaa070-B28","volume-title":"Essential Medical Statistics","author":"Kirkwood","year":"2003","edition":"2nd edn"},{"key":"2020092423551281200_keaa070-B29","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511973420","volume-title":"Negative Binomial Regression","author":"Hilbe","year":"2011","edition":"2nd edn."},{"key":"2020092423551281200_keaa070-B30","year":"2013"},{"key":"2020092423551281200_keaa070-B31","volume-title":"Epidemiologic analysis with a programmable calculator. Report 79-1649","author":"Rothman","year":"1979"},{"key":"2020092423551281200_keaa070-B32","year":"2015"},{"key":"2020092423551281200_keaa070-B33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2020092423551281200_keaa070-B34","doi-asserted-by":"crossref","first-page":"R1072","DOI":"10.1186\/ar1789","article-title":"Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides","volume":"7","author":"Bonaci-Nikolic","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2020092423551281200_keaa070-B35","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/S0041-1345(02)03514-5","article-title":"Infectious complications of immunosuppressive treatment for anti-neutrophil cytoplasm antibody-related vasculitis","volume":"34","author":"Koselj-Kajtna","year":"2002","journal-title":"Transplant Proc"},{"key":"2020092423551281200_keaa070-B36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2020092423551281200_keaa070-B37","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1473-3099(18)30279-2","article-title":"Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial","volume":"18","author":"Fisher","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/3014\/33790226\/keaa070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/10\/3014\/33790226\/keaa070.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T16:39:04Z","timestamp":1665765544000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/10\/3014\/5803119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,3,11]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa070","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,3,11]]}}}